Drugs / AZD0449
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03766399 | Nov 2018 → Jun 2021 | asthma | AstraZeneca | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AZD0449 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03766399 ↗ |
| Route | Inhaled | “single inhaled AZD0449 nebulizer suspension” NCT03766399 ↗ |